Biotech

All Articles

Capricor portions even more information for DMD treatment after starting BLA

.Capricor Therapies is actually taking a victory tour for their stage 2 Duchenne muscle dystrophy (D...

FDA areas Kezar lupus trial in hold following 4 person deaths

.The FDA has placed Kezar Lifestyle Sciences' lupus trial on grip after the biotech hailed four deat...

Phase 3 Scholar Stone trial attacks SMA goal, sending stock up 200%

.A period 3 trial of Intellectual Rock's vertebral muscle degeneration (SMA) applicant has actually ...

CAMP 4 is actually latest to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Therapeutics has marked out think about a $67 thousand IPO, with inflammation-foc...

Galecto purchases leukemia medication, loses bone cancer cells possession in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis candidate sent out Galecto on a hunt...

Judo throws down $100M to knock senseless kidney condition

.Taking the floor covering is actually Judo Biography, an ambitious biotech equipped with $one hundr...

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has actually paid off CSPC Drug Group $100 thousand for a preclinical heart attack medi...

Zephyrm looks for Hong Kong IPO to fund period 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock exchange, filing (PDF) for an IP...

Frazier Life Sciences collects $630M for tiny, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an additionally $630 million for its own fund f...

GigaGen achieves up to $135M BARDA bucks to beat botulism

.Antitoxin connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own tec...